Teniposide, a topoisomerase II inhibitor, prevents chromosome condensation and separation but not decondensation in fertilized surf clam (Spisula solidissima) oocytes.
DNA topoisomerase II has been implicated in regulating chromosome interactions. We investigated the effects of the specific DNA topoisomerase II inhibitor, teniposide on nuclear events during oocyte maturation, fertilization, and early embryonic development of fertilized Spisula solidissima oocytes using DNA fluorescence. Teniposide treatment before fertilization not only inhibited chromosome separation during meiosis, but also blocked chromosome condensation during mitosis; however, sperm nuclear decondensation was unaffected. Chromosome separation was selectively blocked in oocytes treated with teniposide during either meiotic metaphase I or II indicating that topoisomerase II activity may be required during oocyte maturation. Teniposide treatment during meiosis also disrupted mitotic chromosome condensation. Chromosome separation during anaphase was unaffected in embryos treated with teniposide when the chromosomes were already condensed in metaphase of either first or second mitosis; however, chromosome condensation during the next mitosis was blocked. When interphase two- and four-cell embryos were exposed to topoisomerase II inhibitor, the subsequent mitosis proceeded normally in that the chromosomes condensed, separated, and decondensed; in contrast, chromosome condensation of the next mitosis was blocked. These observations suggest that in Spisula oocytes, topoisomerase II activity is required for chromosome separation during meiosis and condensation during mitosis, but is not involved in decondensation of the sperm nucleus, maternal chromosomes, and somatic chromatin.
Wright
S J
SJ
Integrated Microscopy Resource for Biomedical Research, University of Wisconsin, Madison 53706.
Schatten
G
G
D000818:Animals; D049872:Bivalvia / Q000196:embryology*; D002875:Chromosomes / Q000187:drug effects / Q000502:physiology*; D004250:DNA Topoisomerases, Type II / Q000494:pharmacology*; D005307:Fertilization in Vitro; D008540:Meiosis; D008856:Microscopy, Fluorescence; D008938:Mitosis; D009865:Oocytes / Q000502:physiology* / Q000648:ultrastructure; D013713:Teniposide / Q000494:pharmacology*; D059005:Topoisomerase II Inhibitors
D059005:Topoisomerase II Inhibitors; D013713:Teniposide; D004250:DNA Topoisomerases, Type II